Recent Quotes (30 days)

You have no recent quotes
chg | %

Cephalon, Inc.


Officers and directors

J Kevin Buchi
Chief Financial Officer Executive Vice President
Peter E Grebow
Executive Vice President Worldwide Technical Operations
Joseph Caminiti
Senior Management (Senior Vice President General Manager Director)


41 Moores Rd
Malvern, PA 19355-1113
+1-610-344-0200 (Phone)
610-738-6590 (Fax)

Website links

Cephalon has a handful of powerful specialty drugs. The company's research, development, manufacturing, and marketing activities focus on therapies for central nervous system (CNS) disorders, cancer, pain, and inflammatory disease. Its NUVIGIL and PROVIGIL drugs treat the sleep disorder narcolepsy. The company's other top sellers are cancer drug TREANDA, cancer pain medications ACTIQ and FENTORA, epilepsy treatment GABITRIL, and muscle relaxant AMRIX. Its eight major products are primarily sold in the US and Europe. Cephalon was acquired by top generic drugmaker Teva Pharmaceutical Industries in 2011.

Related companies